Core-shell nanostructures, have been investigated extensively for the encapsulation, delivery, and targeting of hydrophobic drugs. In this context, polymeric micelles have reached clinical trials in cancer therapy. [1] [2] [3] [4] However, a main disadvantage is their limited physical stability under extreme dilution in body fluids. 5 Our recent efforts are focused on innovative approaches towards the design and synthesis of amphiphilic nanomaterials that, on the one hand, are as effective as polymeric micelles in terms of hydrophobic drug encapsulation, and, on the other, display maximum physical stability and resistance against dilution. In the past, we employed nanodiamonds as particulate anchors for the conjugation of polymeric amphiphiles made of poly(ethylene glycol)-
b-poly(epsilon-caprolactone) (PEG-b-PCL)
. 6 These core-anchored nanomaterials were very stable in suspension, encapsulated up to 17.5% w/w of the hydrophobic drug nitazoxanide and sustained its release in vitro by anomalous transport. This was a significant finding, since most strategies proposed to stabilize polymeric micelles tend to decrease their loading capacity and/or compromise the integrity and the activity of the encpasulated cargo. 5, 7 We are interested to explore the versatility of this approach and to extend it to inorganic nanomaterials with different nanostructures and morphoplogies.
Boron nitride nanotubes (BNNTs), exceptionally strong and inert materials, 8 were
shown to be non-toxic as long as their length does not exceed a few microns. 9 Pristine
BNNTs are hydrophobic and do not disperse well in water, a fundamental drawback towards their utilization in biomedical applications. Their dispersibility in aqueous media is improved upon adsorption of water-soluble polymers, 10, 11 such as poly(Llysine) 12 , or by exposing BNNTs to ammonia plasma, which increases the number of active N sites. Ammonia plasma is believed to generate a coordination bond through charge transfer from N to B, when the energy barrier is below 0.45 eV. 13, 14 A milder approach consists in treating BNNT dispersions in hydrophilic solvents with hydrophilic primary amines, such as glycine or aminoethanol that form a strong N-B charge transfer bond interaction. 15, 16 It is also possible to oxidize B with concentrated nitric acid to produce -OH moieties. 17 These strategies paved the way to improve the physical stability of BNNT aqueous dispersions. and serve as intracellular nano-delivery agents. 16 To the best of our knowledge, this represents the first report ever on the encapsulation of a hydrophobic cargo within
BNNTs. Rod-shaped nanoparticles are known to be internalized efficiently by cells via active uptake. 19, 20 These properties make BNNTs appealing candidates for encapsulation and delivery applications.
BNNTs display extremely high surface-to-mass ratio 21 which, a priori, enables higher weight ratio of surface modification than other very dense ceramic nanomaterials currently under investigation (e.g., nanodiamonds). We hypothesized that BNNTs oxidized on the surface to display reactive -OH moieties could serve as anchors for the conjugation of monofunctional amphiphilic diblocks, leading to hybrid core-shell amphiphiles with superior physical stability and encapsulation features than regular polymeric micelles ( Figure 1A) . We set up to confirm the valididy of this strategy using a monofunctional PEG-b-PCL diblock copolymer as amphiphilic coating. The successful outcome of this study, that to the best of our knowledge represents the report on the surface modification of BNNTs by conjugation of an amphiphilic copolymer, is reported here. The PEG-b-PCL copolymer molecular weight of 7800 g/mol (calculated by 1 H NMR) and hydrophilic-lipophilic balance of ≅ 12.8 was synthesized by ringopening polymerization of ε-caprolactone (CL), using the terminal -OH group of a capped PEG (PEG, molecular weight of 5000 g/mol) as initiator in the presence of tin(II) 2-ethylhexanoate (SnOct) as catalyst ( Figure 1B) . 22 The Mn of the PCL block and of PEG-b-PCL was determined by 1 H NMR (in chloroform-d) using the areas of the signal at 3.3 ppm, due to the terminal methyl protons of PEG, and at 2.25 ppm attributed to the methylene protons of PCL ( Figure S1 ). Gel permeation chromatography (GPC) of the copolymer presented a single monomodal elution band of low polydispersity (Đ = 1.14) ( Figure S2 , Table S1 ). The diblock was reacted with (Table S1 ). Thermogravimetric analysis (TGA) of glycine functionalized BNNTs after the cutting process 16 and before treatment nitric acid showed a weight loss of 6% w/w at 370°C (Figure 2A) , most probably related to the degradation of glycine residues. TGA analysis of hybrid BNNT-PCL-b-PEG showed a weight loss of 64% w/w over a wide temperature range (~200-585°C) corresponding to the degradation of both PEG and PCL (Figures 2A,S4 ). This high conjugation extent (based on wt%) can be probably attributed to the high surface density of -OH groups generated on the surface of the nanotubes upon oxidation and the very low tap density of BNNTs of approximately 0.25 g/cm 3 . 24 The Figure 2D) . The statistically significant decrease in Dh between days 0 and 1 (P <0.01) indicated a time-dependent homogenization effect of the hydrophilic PEG shell due to a more complete dispersion of the nanotubes. 25 Then, the size change was not statistically significant.
The use of inorganic nanotubes by parenteral routes (e.g., intravenous) has been proposed, though they rise serious safety concerns. [26] [27] [28] Some researchers observed that oral administration of carbon nanotubes, even at very high doses (1,000 mg/kg bodyweight), do not show toxicity. 26 Moreover, nanotubes could be entrapped by mucus and thus perform as mucoadhesive nanocarriers. 29 Thus, in view of their shape, the good chemical stability of PCL copolymers in water that undergo degradation at very slow rate and the envisioned good stability of the ester link between the nanotube and the diblock copolymer that is protected from the outer medium (e.g., acid gastric fluids) by the PCL coating, the hybrid core-shell materials described here were designed for ultimate use as a valuable delivery platform for non-parenteral in general and oral drug delivery in particular. Investigating the stability of the hybrid nanomaterials in gastrointestinal-like medium was beyond the scope of this work and will be studied in the future. Eventually, to prevent any hydrolysis due to the acid gastric medium and ensure full chemical stability, the nanoparticles could be encapsulated within a gastro-resistant capsule that disintegrates exclusively in the small intestine and thus, releases the cargo. In this context, next, we evaluated the cell compatibility of BNNT-OH and BNNT-PCL-b-PEG towards the Caco2 cell line, a standard model of the intestinal epithelium, for the first time. 30, 31 For this, we used the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The time for the assay (24 h) was chosen considering that in oral administration, the transit time is up to 6 h. 32 Good cell compatibility was observed at relatively low BNNT-OH and BNNT-PCL-b-PEG concentration (5-10 µg/mL). Increasing the BNNT concentration resulted in a slight (not statistically significant) decrease in cell viability (64-66% ) for 50 g/mL (Figure 3) . Previous works reported on the good cell compatibility of BNNTs up to a concentration of 20 g/mL. 33 In this sense, our findings are promising, especially considering the higher sensitivity of in vitro models with respect to in vivo ones. 34 As the BNNT concentration reached 70 g/mL, the cytotoxicity of BNNT-OH increased significantly (viability < 40%). In contrast, the cell viability of BNNT-PCL-b-PEG remained similar (~65 %). This result is important as it demonstrates the outstanding contribution of the polymer shell in enhancing the cell compatibility of BNNTs. Assays utilizing more complex in vitro models of intestinal mucosa, such as comprising the coculture of Caco2 cells and mucin-secreting goblet cells, will be performed to ensure the effectiveness of the copolymer shell in increasing the compatibility of hybrid materials containing BNNTs and also assess mucoadhesion. To challenge the encapsulation performance of the BNNT-PCL-b-PEG materials described here, we used curcumin (CUR), a hydrophobic molecule of very low solubility in water (1 μg/mL). Curcumin is a natural polyphenol investigated as antioxidant, anti-inflammatory, 35 and currently in Phase II clinical trials for the chemotherapy of prostate cancer. 36 However, low aqueous solubility, fast degradation, and rapid clearance all together, severely limit the oral bioavailability of CUR, jeopardizing the development of pharmaceutical products, further clinical evaluations, and its eventual approval as drug. 
BNNT-PCL-b-PEG
The underlining assumption in designing BNNT-PCL-b-PEG hybrid materials was that the the hydrophobic PCL domains would act as reservoir for hydrophobic drugs, wich would strongly enhance drug loading efficiency. To test this hypothesis, we compared the CUR loading efficiency of BNNT-PCL-b-PEGs with the loading efficiency of glycine-treated BNNTs, 16 where CUR was loaded in the BNNTs inner channel under reduced pressure.
Specifically, in a first step, we incorporated CUR inside the inner tube of BNNT-PCLb-PEGs by using the capillary forces as described previously. The recovered material was washed profusely with acetone to remove excess CUR and dried . In a second step, CUR was incorporated into the PCL domains by the solvent evaporation method: the recovered powder was dispersed in water ; then, a CUR solution in acetone was added dropwise into the BNNTs aqueous dispersion. After acetone evaporation, the dispersion was subjected to centrifugation; the pellet was washed several times with water and then freeze-dried. 40 The recovered dry powder was re-dispersed in ethanol and subjected to centrifugation. the the CUR concentration in the supernatant measured by UV spectrophotometry ( = 425 nm) employing a calibration curve in ethanol (see experimental section). The CUR load in the solid was 31.3% w/w (based on dry weight), representing a 313-fold increase in its apparent nanomaterial separated by centrifugation and solubility (in drug-loaded nanotubes dispersion of 1 mg/ml) with respect to the aqueous intrinsic solubility. These findings confirm the key role played by the PCL domain in hosting the hydrophobic cargo by allowing a 2.4-fold increase of the encapsulation capacity with respect to the glycine-coated BNNTs. 16 This performance is unprecedented for the encapsulation of hydrophobic molecules by BNNTs and represents an important improvement, compared to standard polymeric micelles. Next, we will investigate other boron nitride derivatives with different microstructure and morphology and their interactions with relevant biological systems.
